The results of DNA analysis are presented for a series of 90 couples, with one partner at 50% risk for Huntington's disease (HD), who were referred for exclusion testing in pregnancy over a three year period. Thirty-seven couples were studied in detail. The aims of the study were to evaluate attitudes towards prenatal testing, before pregnancy and afterwards, and the effectiveness of our counselling and methods of organising the service. Problems which could arise in relation to presymptomatic testing are documented.
presymptomatic testing for the individual subject, and exclusion testing in pregnancy, which alters the risk to the fetus but leaves unchanged the parents' risk.2 Both types of testing depend on a linkage study, but the requirements in terms of family structure are much more easily met for prenatal testing than for presymptomatic testing.3 Thus, family members who want to have children at low risk for HD (in the absence of recombination) may choose prenatal testing because their family structure is inadequate for prediction for themselves, or because they do not wish to alter their own risk.
While considerable discussion has taken place regarding presymptomatic testing, 46 with some preliminary results reported,7-9 exclusion testing has received much less consideration although this type of testing raises specific ethical and counselling issues not applicable to prediction for the individual subject.
Results are presented for a series of 90 couples referred over three years for consideration of exclusion testing in pregnancy; we have previously reported on nine pregnancies occurring in this seriesl' and that number had risen to 19 by May 1988. " Thirty-seven couples have been studied in detail. The aims of the study were to evaluate attitudes toward prenatal testing, before pregnancy and afterwards, to test the effectiveness of our counselling, and the organisational aspects of our protocol, and to gain experience in problems related to the presymptomatic testing project which was then being developed.
The numbers in the study were too small to permit correlation of the clinical and demographic data with attitudes towards and outcomes of testing: this awaits a larger longitudinal study.
Patients and methods
These have been briefly described previously in a report on 55 couples referred for pre-pregnancy typing'0; the series has been extended by 35 In the study group, 15 patients were from Wales and 22 came from outside the region. All had been counselled previously, either by the referring genetic centre or were already known to two of us (AT and OQ). In 33 cases the diagnosis of HD in the parent of the consultand was confirmed by review of medical records supported by a family history. In four cases the clinical criteria were met, but information on previous generations was lacking. These couples were advised to wait for necropsy to support or disprove the presumptive diagnosis, but three decided to continue with pre-pregnancy testing for informativeness. At least two interviews, lasting between one and two hours each, were arranged; couples normally came together and one joint interview was mandatory before prenatal testing was undertaken. At the first interview(s) basic clinical and demographic information relating both to the at risk person and his/her partner was collected. The couple were also encouraged to describe their experience and understanding of the illness and how long they had known about the diagnosis in the affected parent.
A full explanation of the testing procedure was given. It was stressed that the risk to the fetus could be raised to the parent's risk or lowered to less than 3%, but that the parent's risk remained unchanged, and that if termination of pregnancy was unacceptable the test was inappropriate. The possibility of a 'partially informative' situation was also discussed. Attitudes towards predictive testing and other options were explored. Publications describing the test and the procedure of chorion biopsy, including the risks, were always offered.
When the results of testing for informativeness were known, a further interview was arranged and the couple's understanding of and attitudes towards prenatal testing evaluated.
On notification of a pregnancy, transcervical or transabdominal chorion villus biopsy was used to obtain fetal DNA samples at 8 to 10 weeks' gestation. Biopsy results were notified to the referring genetic centre, usually within two weeks. For the Welsh patients, results were given face to face (never over the telephone) and where termination was appropriate it was performed the day after. All the Welsh patients were followed up afterwards.
The method of DNA analysis and fetal sampling has been described elsewhere,'0 but the number of polymorphisms available for study has increased to 18 ( Seven of these couples withdrew when the DNA analysis was incomplete and thus five results were still uninformative and two partially informative. For five couples the family structure was less than ideal as one parent was missing in each case (non-paternity was responsible for one of these). Another couple was referred when already pregnant and the other conceived within three months of the referral; the time was insufficient to obtain an informative result and both women elected to continue with their pregnancies. Subsequently, all seven couples asked for further testing to be abandoned; four women have subsequently had children, one has decided not to have more children, one is pregnant, and one woman, who miscarried, has since broken off the relationship with the at risk partner so further testing is irrelevant.
Seven other couples received an informative prepregnancy result but decided against prenatal testing before becoming pregnant. Two will not have children or further children; one of these couples has chosen AID. Three have had children; one is actively trying to become pregnant and one has chosen presymptomatic testing instead, as the family structure is suitable. Five further women declined prenatal testing after becoming pregnant but before chorion villus sampling was undertaken.
The reasons why prenatal testing was not preferred, after initial interest was expressed, are known for 18 couples and are set out in table 3. Many couples had more than one reason: the most important was dislike of termination of pregnancy, given by 16 couples (89%), some of whom had been influenced by a previous termination. Other contributory factors related to children already born; two women worried about the effect on the first child if the second child's risk status was different. Two felt that they could not afford a termination of pregnancy as they did not want to increase the age gap between first and second children. Maternal age, which referred to age 29 and over, was also influential. Five women felt that they could not afford to lose a baby at that age.
FURTHER RESULTS FOR 37 COUPLES STUDIED IN DETAIL
Demographic data The at risk group divided into 21 females and 16 males, in the age range 20 to 37 years. Their partners were in a similar age group. Just over 50% were in their late twenties and early thirties. It is noteworthy that there were no teenagers in this series. Miscarriage rate associated with chorion biopsy 3 21
Religious grounds 2 11 Error rate in test 1 6
Unconfirmed family history 1 6 Total 40
Over half the subjects belonged to social classes I and II, contrasting with the distribution found by an earlier study of HD in South Wales,'2 and with the distribution in the general population'3 ( Five couples were not using any contraceptive methods at the time of referral and two women were already pregnant, but one pregnancy was not known about at the time.
Clinical data Past medical history indicated no significant physical problems; the great majority of applicants considered themselves to be in good health and only four admitted to being on long term medication (three for asthma and one for hypothyroidism).
At the time of referral, six subjects at risk (three men, three women) gave a recent history of experiencing significant symptoms of depression and anxiety, but only one had seen a psychiatrist, after taking a the part of men in this selected group to try to spare their wives unnecessary intervention in pregnancy.
For seven subjects at risk, the major reason given for wanting prediction was to reduce uncertainty, and, for four subjects, to make decisions in relation to childbearing, that is, whether to have any children at all or further children, whether to undergo prenatal testing, or to decide on the timing of pregnancies. Three women remarked that if they knew they would be affected they would have their children as quickly as possible so that they could bring them up before onset of symptoms. The remaining two subjects wanted to know their status for the sake of children already born, but not necessarily immediately. One of these, a woman, has two children, only the second one of which has been tested prenatally and is at low risk. She says she intends to seek presymptomatic testing when her first born child, now an infant and currently at close to 25% risk, is in her late teens.
Seven at risk subjects wanted both tests but at different times and for different reasons. They wanted prenatal testing now and presymptomatic testing, to reduce uncertainty, some years hence, when they would be more able to tolerate an adverse result. It was pointed out to them that presymptomatic testing could show that a termination had been needless.
Nine couples had an uncertain or negative attitude towards both exclusion and presymptomatic testing. Five couples would have preferred presymptomatic testing to exclusion testing but three had a clearly inadequate family structure.
Understanding of exclusion testing All couples received full counselling before blood samples were taken and typed. Nevertheless The information about chorion villus sampling and the residual risk to the fetus with a negative result was understood and retained by 30 (8 1%) and 34 (92%) of couples respectively.
Reasons for requesting exclusion testing At the time of referral, all the couples counselled, except one, were motivated by one or both of the following reasons: (1) to seek information about the testing procedure, (2) to have a child of their own, predicted to be at low risk of carrying the HD gene. As discussed earlier, the only request which was refused was for the status of the child to be assessed. This group were currently only interested in having children that were biologically their own. Some had already considered other options; five couples would have adopted had it been possible. None had wished to consider fostering. Four couples had seriously discussed AID but none had actually attended the relevant clinic and the wives were averse to the procedure. Two of these couples were prepared to look at AID again in the future if, in one case, further testing using different probes still proved uninformative, and, in the second, if predictive testing for the husband became possible and gave an adverse result.
A number had seriously considered having no children at all until they heard of the test, and most desired to limit their family size to one or two children at the most.
Discussion
Our initial reports'0 11 A couple usually preferred to maintain a detached attitude towards the pregnancy and not to inform friends and relatives until the result of the chorion biopsy was known, and to continue the secrecy if a termination was necessary. In this circumstance, obviously, confidentiality needs to be scrupulously maintained, which can need considerable vigilance if genetic staff are already known to and are in contact with the extended family. Arrangements for clinic appointments, sending letters, and making and receiving telephone calls may need to be carefully scrutinised beforehand to avoid arousing suspicion.
If unexpected delays in giving a result occurred, either in the pre-pregnancy stage or (in two cases) after chorion villus biopsy had been performed, most consultands needed to be reassured that the delay was not because of "something wrong with their blood" but technical problems in the laboratory beyond their control. Reassurance was also often needed when a fetus was given a raised risk, as some subjects felt that their own risk had also been raised.
In the event of an adverse prenatal test, termination needs to be offered with the minimum of delay and at the same time as the result is given. On two occasions it proved necessary to review our procedure with our Welsh patients when the results were 'guessed' beforehand: once when a home visit was made as the quickest method of communicating the result, and on a second occasion when the clinic appointment was made not in the Genetic Centre but in the antenatal clinic.
The ethical issues surrounding prenatal exclusion testing have received scant attention to date.'0 16 17 Arguably the most important concerns termination of pregnancy when the fetus shares the same risk as the parent.
Although a child who shares his parent's risk has an equal chance of being unaffected, should the parent develop signs of HD the child is known immediately to be at very high risk of also being a gene carrier.
This risk alteration is not under the child's control and effectively removes from him freedom of choice regarding knowledge of his own-status, which many centres believe belongs to him. ' Other aspects of counselling included the possible psychological consequences for the parents and child if the status of the two was linked. Couples were invited to consider how they might feel if the parent at risk and his offspring were, in effect, 'diagnosed' simultaneously. There is also the question of the anxiety which they could feel even if the parent never developed any signs of HD. Many at risk persons 'symptom search' 0; in the authors' experience those who do not feel any anxiety about their at risk status are not likely to be motivated to seek testing. It can be assumed, therefore, that their anxiety about themselves would be heightened if it was thought that their child could also be implicated. The psychological effects of this anxiety both on the parent and the child are unknown. There is also the question that a child known to be at very high risk of carrying the gene (if his parent became affected) could be at risk of being discriminated against with regard to educational and employment opportunities.2"-23
These aspects will assume even greater importance when subjects with an adverse result on presymptomatic testing seek prenatal testing. Four recent American studies, 7 18 24 25 which surveyed attitudes towards prenatal testing found that 32% to 65% said they would use it. A worrying finding in three of these studies was the number of at risk subjects in this group (63% to 71%) who said they would continue with a pregnancy even if they themselves had been given a positive result on presymptomatic testing and the fetus had been found to share the same risk.
All four surveys attempted to estimate the level of knowledge possessed by their participants. The 494I/er, Qu)ar-rell, Lazarou, Meredith, Harper number in favour of continuing with a pregnancy in such circumstances appeared to be in inverse relationship to their level of understanding. Kessler et a124 remarked that 79% had not received genetic counselling, and that "the level of information was surprisingly low"; 71% of this group was uncommitted to termination of pregnancy. Meissen and Berchek25 also commented on the low knowledge of predictive testing and that nearly half of those who could not answer any knowledge questions correctly intended to use the prenatal test; 66% might not abort whatever the result. Markel et all7 found the level of knowledge high (but did not ask questions specific to prenatal test understanding); 63% were unhappy about termination. Mastromauro et all8 did not ask specifically about respondent's attitudes to termination of pregnancy but commented that the level of knowledge about testing was good; it is noteworthy that their survey contained the lowest percentage number (32%) who said they would use prenatal testing.
We wonder whether the surprising finding that so many in the American studies say they would continue with a very high risk pregnancy is related to the amount and type of counselling received. The problem did not arise in the present series since all 10 high risk pregnancies were terminated, but one high risk pregnancy which was not terminated has been reported elsewhere. Some evidence is available that women seeking termination for genetic reasons can suffer intense and prolonged grief which, if unresolved, can affect their health and attitudes towards future children.27 28 All the Welsh patients were followed up after termination and offered bereavement counselling, but none accepted, although some couples commented that it had been very helpful to know that two of the authors (AT and OQ) were available to give support. None seemed to suffer more than transient feelings of loss. This may be partly because, in all cases except one, termination was carried out in the first trimester, in contrast to the earlier studies when fetal testing was by amniocentesis and termination was performed at a later stage. Also all these women were motivated to try again and all have achieved low risk pregnancies, except two; one of these women has been waiting for the result of presymptomatic testing on her at risk husband before embarking on a second pregnancy.
Women who received a low risk result and whose pregnancies came safely to term universally experienced gladness and delight. If they had undergone previous terminations they felt that their previous 'sacrifices' had been worthwhile, and several couples commented that they had been brought closer together by the experience.
The position of children in the same family, who have differing risks owing to prenatal testing having been undertaken for one but not the other(s), has implications for counselling. This has happened once in this series and will undoubtedly happen again. Follow up studies are needed since it is conceivable that family attitudes towards them would differ, with adverse implications for the untested child, particularly if it became known that the at risk parent was a gene carrier and the child's risk, therefore, was further raised. Some of the findings of this survey have implications for presymptomatic pre-test counselling and testing. Subjects requesting presymptomatic testing, after having used prenatal testing, could discover that a termination had been unnecessary. TIhis situation could have occurred in this study if the at risk person had not been given an increased risk.
It was also helpful to discover that almost half of the spouses of persons at risk who were in favour of presymptomatic testing held a different viewpoint and did not want their partners to be tested. A similar lack of concordance was found in a smaller study in Belgium29 where only seven out of 18 couples were in complete agreement. Considering the implications of a positive result, it might be considered hazardous to the marital relationship to proceed with testing while disagreement exists.
Problems relating to premature knowledge of a test result can arise if a person at risk, whose DNA has already been typed, later requests presymptomatic testing. In the case already described, a careful procedure was worked out, which involved not typing an affected member until a late stage, in order to avoid knowing the applicant's status before pre-test counselling had been completed.
Another problematical situation relates to sibs, two pairs of which presented in this series, both of whom were informative for prenatal testing. Each sib held opposing views on the question of presymptomatic testing for themselves. Altering the risk for one could lead to an automatic risk alteration for the other, who had not requested it, because DNA typing results for both would be available. It is also conceivable that it would be possible to discover whether further prenatal testing is necessary. Inadvertent risk alteration can also occur if too much information is gathered in the course of pregnancy exclusion testing. 
